Literature DB >> 2379526

Biliary secretion of felodipine metabolites in man after intravenous [14C]felodipine.

T A Sutfin1, T Lind, M Gabrielsson, C G Regårdh.   

Abstract

The biliary secretion of [14C]felodipine in 4 healthy human subjects was studied by use of the multiple marker dilution principle with double lumen tubes placed in the stomach and intestine. Insignificant amounts of 14C activity were recovered from gastric aspirates. The individual recovery from intestinal aspirates varied from 2.9 to 8.5% of the dose of radioactivity over the period of 4.5 h after dosing. Less than 0.1% was identified as unchanged felodipine. The results show that biliary secretion is a minor route of elimination of felodipine or its metabolites. Bile collection for 4.5 h had no significant effect on the pharmacokinetics of felodipine, although the 72 h urinary recovery of radioactivity tended to be lower when bile was collected (59%) than in the control experiment (66%).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379526     DOI: 10.1007/bf02336677

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Biliary excretion of intravenous [14C] omeprazole in humans.

Authors:  T Lind; T Andersson; I Skånberg; L Olbe
Journal:  Clin Pharmacol Ther       Date:  1987-11       Impact factor: 6.875

2.  Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1985-04

3.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

4.  Quinidine reduces biliary clearance of digoxin in man.

Authors:  B Angelin; A Arvidsson; R Dahlqvist; A Hedman; K Schenck-Gustafsson
Journal:  Eur J Clin Invest       Date:  1987-06       Impact factor: 4.686

5.  Felodipine kinetics in healthy men.

Authors:  B Edgar; C G Regårdh; G Johnsson; L Johansson; P Lundborg; I Löfberg; O Rönn
Journal:  Clin Pharmacol Ther       Date:  1985-08       Impact factor: 6.875

6.  Effects of biliary excretion on the disposition of felodipine and metabolites in the rat.

Authors:  T A Sutfin; M Gabrielsson; C G Regårdh
Journal:  Xenobiotica       Date:  1987-10       Impact factor: 1.908

Review 7.  Biliary excretion of drugs in man.

Authors:  D E Rollins; C D Klaassen
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

8.  Identification of felodipine metabolites in rat urine.

Authors:  K J Hoffmann; L Weidolf
Journal:  Biomed Mass Spectrom       Date:  1985-08

9.  In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.

Authors:  C Bäärnhielm; H Dahlbäck; I Skånberg
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-08

10.  Cytochrome P-450-dependent oxidation of felodipine--a 1,4-dihydropyridine--to the corresponding pyridine.

Authors:  C Bäärnhielm; I Skånberg; K O Borg
Journal:  Xenobiotica       Date:  1984-09       Impact factor: 1.908

View more
  3 in total

Review 1.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

2.  The effect of felodipine on bile flow in pentobarbital anaesthetized rats and conscious rats receiving bile salt supplementation.

Authors:  S X Wang; T A Sutfin; C G Regårdh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Oct-Dec       Impact factor: 2.441

3.  A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction Modeling.

Authors:  Laura Maria Fuhr; Fatima Zahra Marok; Maximilian Mees; Felix Mahfoud; Dominik Selzer; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.